Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 4089-4094

  Donath, Marc Y ^a   Jenni, Rolf ^a   Brunner, Hans Peter ^a   Anrig, Marcel ^a   Kohli, Stefanie ^a   Glatz, Yvonne ^a   Froesch, E Rudolf ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GROWTH HORMONE; INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C;

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; GROWTH HORMONE BLOOD LEVEL; HEART EJECTION FRACTION; HEART FUNCTION; HEART OUTPUT; HEART PERFORMANCE; HEART RATE; HEART STROKE VOLUME; HUMAN; HUMAN EXPERIMENT; INOTROPISM; INSULIN BLOOD LEVEL; MALE; METABOLISM; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; EXERCISE TEST; HEART DISEASES; HEART RATE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OXYGEN CONSUMPTION; RECOMBINANT PROTEINS;

EID: 0029847998     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.4089     Document Type: Article

References (49)

1. Florini JR, Ewton DZ. 1992 Induction of gene ex pression in muscle by the IGFs. Growth Regul. 2:23-29.
2. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, et al. 1993 Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 87:1715-1721.
3. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger. HM. 1994 Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha actin of adult cardiomyocytes. Proc Natl Acad Sci USA. 91:1686-1690.
4. Vetter U, Kupferschmid C, Lang D, Pentz S. 1988 Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro. Basic Res Cardiol. 83:647-54.
5. Johnston DM, Gluckman PD, Bratt CM, Ambler GR, Lubbe WF. 1994 Insulinlike growth factors elicit positive inotropic responses in isolated rat heart [Abstract]. Growth Regul. 4:44.
6. Guler H-P, Zapf J, Scheiwiller E, Froesch ER. 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA. 85:4889-4893.
7. Donath MY, Gosteli-Peter MA, Froesch ER, Zapf J. IGF-I and GH promote cardiac hypertrophy, stimulate myofibrilar genes and decrease ANF expression in adult rats [Abstract]. Proc of the Int Workshop on Cardiac Growth and Regeneration. 1994;53.
8. Ambler GR, Johnston BM, Maxwell L, Gavin JB, Gluckman PD. 1993 Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I. Cardivasc Res. 27:1368-1373.
9. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J. 1995 Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 95:619-627.
10. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. 1995 Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 92:8031-35.
11. Donath MY, Zierhut W, Gosteli-Peter MA, Froesch ER, Zapf J. Effects of insulin-like growth factor (IGF) I on cardiac growth and cardiac proteins expression after induction of cardiac hypertrophy [Abstract], Proc of the 10th Int Congr of Endocrinol. 1996, OR45-48.
12. Copland AC, Nair KS. 1994 Recombinant human insulin-like growth factor I increases forearm blood flow. J Clin Endocrinol Metab. 79:230-232.
13. Fryburg DA. 1994 IGF-I exerts GH and insulin-like actions on human muscle protein metabolism. Am J. Physiol. 267:E331-E336.
14. Kiowski W, Stoschitsky K, Kim JH, Hussain MA, Froesch ER. 1994 Insulin-like growth factor-I causes endothelium-dependent arterial vasodilatation [Abstract]. Circulation. 90:I-242.
15. Russell-Jones DL, Bates AT, Umpleby AM, et al. 1995 A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest. 25:403-411.
16. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL. 1993 Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab. 77:1384-1387.
17. Schalch DS, Turman NJ, Marcsisin VS, Heffernan M, Guler HP. 1993 Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. J Clin Endocrinol Metab. 77:1563-1568.
18. Jabri N, Schalch DS, Schwartz SL, et al. 1994 Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic-patients. Diabetes. 43:369-374.
19. Takano K, Hizuka N, Asakawa K, Sukegawa I, Shizume K, Demura H. 1990 Effects of sc administration of recombinant human insulin-like growth factor I (IGF-I) on normal human subjects. Endocrinol Jpn. 37:309-317.
20. Sahn DJ, DeMaria A, Kisslo J, Weyman A. 1978 The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiography measurements. Circulation. 58:1072-1085.
21. Lewis JF, Kuo LC, Nelson JC, Limacher MC, Quinines MA. 1984 Pulsed doppler echocardiographic determination of stroke volume and cardicac output: clinical evaluation of two new methods using the apical window. Circulation. 70:425-431.
22. Shan DJ. 1985 Determination of cardiac output by echocardiographic Doppler methods: relative accuracy of various sites of measurement. J Am Coll Cardiol. 6:663-664.
23. Dubin J, Wallerson DC, Cody RJ, Devereux RB. 1990 Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J. 120:116-123.
24. Jenni R, Vieli A, Hess O, Anliker M, Krayenbuehl HP. 1981 Estimation of left ventricular volume from apical orthogonal 2-D echocardiograms. Eur Heart J. 2:217-225.
25. Seiler C, Jenni R, Krayenbühl HP. 1991 Intraventricular blood flow during isovolumetric relaxation and diastole in hypertrophic cardiomyopathy. J Am Assoc Echo. 4:247-257.
26. Rokey R, Kuo LC, Zoghidi WA, Limacher MC, Quinones MA. 1985 Determination of parameters of left ventricular diastolic feeling with pulsed Doppler echocardiography: comparison with cinéangiography. Circulation. 71:543-550.
27. Spirito T, Maron BJ, Bonow RO. 1986 Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclear angiographic techniques. J Am Coll Cardiol. 7:518-526.
28. Guler H-P., Schmid C, Zapf J, Froesch ER. 1989 Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA. 86:2868-2872.
29. Hirschberg R, Kopple JD. 1989 Evidence that insulin-like growth factor I increases renal plasma flow and golmerular filtration rate in fasted rats. J Clin Invest. 83:326-330.
30. Schoenle E, Zapf J, Humbel RE, Froesch ER. 1982 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 296:252-253.
31. Courville C, Mason VR. 1938 The heart in acromegaly. Arch Intern Med. 61:704-713.
32. Wright AD, Hill DM, Lowy C, Fraser TR. 1970 Mortality in acromegaly. Q J Med. 39:1-16.
33. Cuneo RC, Salomon F, Wilmshurst P, el al. 1991 Cardiovascular effects of growth hormone treatment in growth hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci. 81:587-592.
34. Merola B, Zittadini A, Colao A, et al. 1993 Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 77:1658-1661.
35. Amato G, Carella C, Fazio S, et al. 1993 Body composition, bone metabolism, heart structure and function in growth hormone-deficient adults before and after growth hormone replacement therapy at low doses. J Clin Endocrinol Metab. 77:1671-1676.
36. Saccà L, Zittadini A, Fazio S. 1994 Growth hormone and the heart. Endocr Rev. 15:555-573.
37. Flyvbjerg A, Jørgensen KD, Marshall SM, Ørskov H. 1991 Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. Am J Physiol. 260:E568-E74.
38. Isgaard J, Nilsson A, Vikman K, Isaksson OGP. 1989 Growth hormone regulates the level of insulin-like growth factor I mRNA in rat skeletal muscle. J Endocrinol. 120:107-112.
39. Gosteli-Peter MA, Winterhalter KH, Schmid C, Froesch ER, Zapf J. 1994 Expression and regulation of insulin-like growth factor I (IGF-I) and IGF binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology. 135:2558-2567.
40. McGuffin JWL, Sherman BM, Roth J, et al. 1974 Acromegaly and cardiovascular disorders. A prospective study Ann Intern Med. 81:11-18.
41. Martins JB, Kerber RE, Sherman BM, Markus ML, Ehrhardt JC. 1977 Cardiac-function in acromegaly. Circulation. 56:863-869.
42. Stout RW. 1990 Insulin and atheroma. Twenty years perspective. Diabetes Care. 13:631-654.
43. Unger RH, Foster DW. 1992 Diabetes mellitus. Textbook of endocrinology. Philadelphia: Saunders.
44. Moller N, Schmilz O, Jørgensen JOL, et al. 1992 Basal and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab. 74:1012-1019.
45. Nikkila EA, Pelkonen R. 1975 Serum lipids in acromegaly. Metabolism. 24:829-838.
46. Hussain MA, Schmitz O, Mengel A, et al. 1993 Insulin-like growth factor I stimulais lipid oxidation, reduces protein oxidation and enhances inulin sensivity in humans. J Clin Invest. 92:2249-2256.
47. Zenobi PD, Holzmann P, Glatz Y, Riesen WE, Froesch ER. 1993 Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia. 36:465-469.
48. Zenobi PD, Graf S, Ursprung H, Froesch ER. 1992 Effects of insulin-like growth factor I on glucose tolerance, insulin levels and insulin secretion. J Clin Invest. 89:1908-1913.
49. Froesch ER, Hussain MA. 1994 Recombinant human insulin-like growth factor-I: a therapeutic challenge for diabetes mellitus. Diabetologia. 37:179-185.